Name: Fixed Asset Turnover

Definition: Fixed asset turnover shows how well the company’s long-term physical assets — factories, equipment, property — are being used to generate sales. A high ratio means the company’s facilities are productive and efficient. A low ratio might signal underused assets or over-investment in equipment that isn’t driving enough sales.

Interpretation:
• In '2021', ACHV's fixed asset turnover was 0.00, illustrating how efficiently fixed assets are generating revenue. Industry average for Biotechnology: In Vitro & In Vivo Diagnostic Substances in '2021' stood at 2.05.
• In '2022', ACHV's fixed asset turnover was 0.00, illustrating how efficiently fixed assets are generating revenue. The figure remained stable compared to '2021'. Industry average for Biotechnology: In Vitro & In Vivo Diagnostic Substances in '2022' stood at 2.03. Industry average declined by 0.02 from previous year.
• In '2023', ACHV's fixed asset turnover was 0.00, illustrating how efficiently fixed assets are generating revenue. The figure remained stable compared to '2022'. Industry average for Biotechnology: In Vitro & In Vivo Diagnostic Substances in '2023' stood at 1.87. Industry average declined by 0.16 from previous year.
• In '2024', ACHV's fixed asset turnover was 0.00, illustrating how efficiently fixed assets are generating revenue. The figure remained stable compared to '2023'. Industry average for Biotechnology: In Vitro & In Vivo Diagnostic Substances in '2024' stood at 1.82. Industry average declined by 0.05 from previous year.
Overall, ACHV's fixed asset turnover has remained generally stable over the past 4 years.

Formula: Fixed Asset Turnover = Net Sales / Net Fixed Assets

Good Range: Ranges from 1 to 5 depending on asset intensity.